"They can drag it out till I'm not here anymore," Kirkland told KETV before he heard the news of the claim's reversal. "And then they win because ... they don't have to pay for it." ...

Delcath Systems markets Hepzato Kit for the treatment of uveal melanoma with unresectable hepatic metastases. Click here to read my analysis of DCTH stock.